Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.

Stone, Gregg W; Witzenbichler, Bernhard; Guagliumi, Giulio; Peruga, Jan Z; Brodie, Bruce R; Dudek, Dariusz; Kornowski, Ran; Hartmann, Franz; Gersh, Bernard J; Pocock, Stuart J; +6 more... Dangas, George; Wong, S Chiu; Fahy, Martin; Parise, Helen; Mehran, Roxana; HORIZONS-AMI Trial Investigators; (2011) Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet, 377 (9784). pp. 2193-2204. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(11)60764-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(11)60764-2

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar